PHARMACOKINETICS OF 3 ORAL FORMULATIONS OF CIPROFLOXACIN

被引：73

作者：

DAVIS, RL

KOUP, JR

WILLIAMSWARREN, J

WEBER, A

SMITH, AL

机构：

[1] UNIV WASHINGTON, DEPT PEDIAT, SEATTLE, WA 98195 USA

[2] UNIV WASHINGTON, DEPT PHARM PRACTICE, SEATTLE, WA 98195 USA

[3] CHILDRENS ORTHOPED HOSP & MED CTR, DIV INFECT DIS, SEATTLE, WA 98105 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1985年 / 28卷 / 01期

关键词：

D O I：

10.1128/AAC.28.1.74

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

收藏

页码：74 / 77

页数：4

相关论文

共 9 条

[1] [Anonymous], 1971, STAT PRINCIPLES EXPT
[2] [Anonymous], 1970, SCI TABLES, P28
[3] INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID
BAUERNFEIND, A
PETERMULLER, C
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) : 111 - 115
[4] PHARMACOKINETICS AND TISSUE PENETRATION OF CIPROFLOXACIN
CRUMP, B
WISE, R
DENT, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) : 784 - 786
[5] INVITRO ACTIVITY OF CIPROFLOXACIN (BAY O 9867)
FASS, RJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) : 568 - 574
[6] GIBALDI M, 1982, PHARMACOKINETICS
[7] COMPARATIVE ACTIVITIES OF CIPROFLOXACIN (BAY O-9867), NORFLOXACIN, PIPEMIDIC ACID, AND NALIDIXIC-ACID
MUYTJENS, HL
VANDERROSVANDEREPE, J
VANVELDHUIZEN, G
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (02) : 302 - 304
[8] INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS
WISE, R
ANDREWS, JM
EDWARDS, LJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) : 559 - 564
[9] PHARMACOKINETICS OF INTRAVENOUSLY ADMINISTERED CIPROFLOXACIN
WISE, R
LOCKLEY, RM
WEBBERLY, M
DENT, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) : 208 - 210